Bubs Australia Ltd Trading Halt Pending FDA Update
Key points
- Bubs Australia Ltd requests trading halt
- Halt pending FDA update announcement
- Trading to resume on 8 September 2026 or earlier
- No other market-sensitive information available
Full summary
Bubs Australia Ltd (ASX: BUB) has requested an immediate trading halt on its securities as it awaits an announcement related to an FDA update. The trading halt is in accordance with ASX Listing Rule 17.1 and will remain in effect until the earlier of the company's announcement about the FDA update results or the resumption of trading on 8 September 2026. The company asserts that there is no other information necessary for the market regarding the trading halt.
Outlook
The company is awaiting an FDA update and will make an announcement once it has the results.
Sign in for more about this company, including guidance changes and other insights.
Sign in